1. Home
  2. Animal Drug Index - F
  3. Firocoxib

Animal NDC 51604-1190-0 Firocoxib

Animal Product Information

Field Name Field Value
Animal NDC Code 51604-1190-0
Proprietary Name Firocoxib What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
Non-Proprietary Name Firocoxib What is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
Labeler Name Cosma Spa
Product Type Bulk Ingredient - Animal Drug
Active Ingredient(s)
  • Firocoxib
Marketing Category BULK INGREDIENT What is the Marketing Category?
Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Firocoxib Images

Firocoxib Animal Product Labeling Information

The product labeling information includes all published material associated to a drug. Product labeling documents include information like generic names, active ingredients, ingredient strength dosage, routes of administration, appearance, usage, warnings, inactive ingredients, etc.

Table of Contents



Package Label.Principal Display Panel



COSMA S.p.A.

Via Colleoni, 15/17

24040 CISERANO (BG) Italy

Telefono: 035.88.30.55

Firocoxib

NDC n: 51604-1190-0

Batch:

CAUTION: "For Manufacturing, Processing, or Repacking. Rx Only"

C.A.S. 189954-96-9

Chemical Name: 3-(Cyclopropylmethoxy)-4-(4-methylsulfonylphenyl)-5,5-dimethylfuranone

Store Condition: Store below 30°C (86°F); excursions permitted to 40°C (104°F)


* The information on this page is for an ANIMAL PRODUCT, please review the complete disclaimer below.